NCT03336567View on ClinicalTrials.gov

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

June 12, 2018

Study Completion Date

June 12, 2018

Conditions
Neoplasms
Interventions
OTHER

Telephonic interview

Subjects with cancer and Oncologists will undergo a semi-structured one-to-one telephonic interview for up to 90 and 60 minutes respectively.

Trial Locations (1)

19426

GSK Investigational Site, Collegeville

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03336567 - Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer | Biotech Hunter | Biotech Hunter